← FDA Drug Approvals (Drugs@FDA)
ABSORICA LD
NDA · New Drug Application · Sponsor: SUN PHARM · Approved 2019-11-05
Drug application
- FDA Application #
NDA211913- Application type
- New Drug Application
- Brand name
- ABSORICA LD
- Generic name
- ISOTRETINOIN
- Active ingredients
- ISOTRETINOIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SUN PHARM
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- First approval
- 2019-11-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown